25 XP   0   0   10

Bioera
Buy, Hold or Sell?

Let's analyse Bioera together

PenkeI guess you are interested in Bioera. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioera. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bioera

I send you an email if I find something interesting about Bioera.

Quick analysis of Bioera (30 sec.)










What can you expect buying and holding a share of Bioera? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
12.8%

What is your share worth?

Current worth
€-0.25
Expected worth in 1 year
€-0.52
How sure are you?
10.3%

+ What do you gain per year?

Total Gains per Share
€-0.27
Return On Investment
-407.7%

For what price can you sell your share?

Current Price per Share
€0.07
Expected price per share
€0.048 - €0.139
How sure are you?
50%

1. Valuation of Bioera (5 min.)




Live pricePrice per Share (EOD)

€0.07

Intrinsic Value Per Share

€5.03 - €6.04

Total Value Per Share

€4.78 - €5.79

2. Growth of Bioera (5 min.)




Is Bioera growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.4m-$2.4m-$400.8k-14.0%

How much money is Bioera making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m$6.2m-$7.7m-518.5%
Net Profit Margin-627.6%-45.0%--

How much money comes from the company's main activities?

3. Financial Health of Bioera (5 min.)




4. Comparing to competitors in the Conglomerates industry (5 min.)




  Industry Rankings (Conglomerates)  


Richest
#242 / 245

Most Revenue
#231 / 245

Most Profit
#211 / 245

Most Efficient
#240 / 245

What can you expect buying and holding a share of Bioera? (5 min.)

Welcome investor! Bioera's management wants to use your money to grow the business. In return you get a share of Bioera.

What can you expect buying and holding a share of Bioera?

First you should know what it really means to hold a share of Bioera. And how you can make/lose money.

Speculation

The Price per Share of Bioera is €0.0674. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.25. Based on the TTM, the Book Value Change Per Share is €-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is €0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioera.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.16-235.5%-0.06-91.9%0.15216.8%-0.01-18.6%-0.02-22.3%
Usd Book Value Change Per Share-0.21-312.0%-0.07-109.9%0.13197.7%-0.03-40.6%-0.03-46.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.018.1%
Usd Total Gains Per Share-0.21-312.0%-0.07-109.9%0.13197.7%-0.03-40.6%-0.03-38.1%
Usd Price Per Share0.46-0.22-0.17-0.25-0.28-
Price to Earnings Ratio-0.73--1.46-0.39--1.40-0.90-
Price-to-Total Gains Ratio-2.20--4.73--0.41--2.85--2.56-
Price to Book Ratio-1.73--1.89-0.66--0.41-0.05-
Price-to-Total Gains Ratio-2.20--4.73--0.41--2.85--2.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.07266394
Number of shares13761
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.07-0.03
Usd Total Gains Per Share-0.07-0.03
Gains per Quarter (13761 shares)-1,019.18-376.24
Gains per Year (13761 shares)-4,076.70-1,504.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4077-40870-1505-1515
20-8153-81640-3010-3020
30-12230-122410-4515-4525
40-16307-163180-6020-6030
50-20384-203950-7525-7535
60-24460-244720-9030-9040
70-28537-285490-10535-10545
80-32614-326260-12040-12050
90-36690-367030-13545-13555
100-40767-407800-15049-15060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%4.07.00.036.4%4.015.00.021.1%8.021.010.020.5%26.021.022.037.7%
Book Value Change Per Share0.02.01.00.0%1.05.05.09.1%1.09.09.05.3%2.018.019.05.1%13.025.031.018.8%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%5.00.034.012.8%5.00.064.07.2%
Total Gains per Share0.02.01.00.0%1.05.05.09.1%1.09.09.05.3%4.018.017.010.3%15.025.029.021.7%

Fundamentals of Bioera

About Bioera

Bioera S.p.A. engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names; and distributes its products through outsourcers. The company was founded in 2004 and is headquartered in Milan, Italy.

Fundamental data was last updated by Penke on 2024-04-19 16:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bioera.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bioera earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Net Profit Margin of -1,702.2% means that €-17.02 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioera:

  • The MRQ is -1,702.2%. The company is making a huge loss. -2
  • The TTM is -627.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,702.2%TTM-627.6%-1,074.6%
TTM-627.6%YOY-45.0%-582.7%
TTM-627.6%5Y-114.8%-512.8%
5Y-114.8%10Y-57.4%-57.4%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,702.2%3.5%-1,705.7%
TTM-627.6%3.8%-631.4%
YOY-45.0%3.7%-48.7%
5Y-114.8%3.1%-117.9%
10Y-57.4%3.7%-61.1%
1.1.2. Return on Assets

Shows how efficient Bioera is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • -105.2% Return on Assets means that Bioera generated €-1.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioera:

  • The MRQ is -105.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-105.2%TTM-41.2%-64.0%
TTM-41.2%YOY36.9%-78.1%
TTM-41.2%5Y-1.7%-39.4%
5Y-1.7%10Y-1.3%-0.4%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-105.2%0.8%-106.0%
TTM-41.2%0.8%-42.0%
YOY36.9%1.0%+35.9%
5Y-1.7%0.7%-2.4%
10Y-1.3%0.8%-2.1%
1.1.3. Return on Equity

Shows how efficient Bioera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • 0.0% Return on Equity means Bioera generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioera:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11.8%+11.8%
TTM-11.8%YOY180.6%-192.5%
TTM-11.8%5Y3.2%-15.0%
5Y3.2%10Y-0.4%+3.6%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.7%-1.7%
TTM-11.8%2.2%-14.0%
YOY180.6%3.0%+177.6%
5Y3.2%2.1%+1.1%
10Y-0.4%2.3%-2.7%

1.2. Operating Efficiency of Bioera.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bioera is operating .

  • Measures how much profit Bioera makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioera:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27.0%+27.0%
TTM-27.0%YOY-37.0%+10.0%
TTM-27.0%5Y-16.0%-11.0%
5Y-16.0%10Y-9.0%-6.9%
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-27.0%3.9%-30.9%
YOY-37.0%6.2%-43.2%
5Y-16.0%5.3%-21.3%
10Y-9.0%5.4%-14.4%
1.2.2. Operating Ratio

Measures how efficient Bioera is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Conglomerates industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Bioera:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.045-0.045
TTM0.045YOY0.080-0.035
TTM0.0455Y0.704-0.659
5Y0.70410Y0.953-0.249
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.532-1.532
TTM0.0451.493-1.448
YOY0.0801.415-1.335
5Y0.7041.384-0.680
10Y0.9531.221-0.268

1.3. Liquidity of Bioera.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bioera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Conglomerates industry mean).
  • A Current Ratio of 0.07 means the company has €0.07 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioera:

  • The MRQ is 0.067. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.181. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.067TTM0.181-0.114
TTM0.181YOY0.328-0.147
TTM0.1815Y0.432-0.250
5Y0.43210Y0.336+0.096
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0671.468-1.401
TTM0.1811.480-1.299
YOY0.3281.465-1.137
5Y0.4321.554-1.122
10Y0.3361.489-1.153
1.3.2. Quick Ratio

Measures if Bioera is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Quick Ratio of 0.02 means the company can pay off €0.02 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioera:

  • The MRQ is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.184. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.184-0.168
TTM0.184YOY0.278-0.094
TTM0.1845Y0.324-0.140
5Y0.32410Y0.454-0.130
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0160.702-0.686
TTM0.1840.725-0.541
YOY0.2780.799-0.521
5Y0.3240.854-0.530
10Y0.4540.863-0.409

1.4. Solvency of Bioera.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bioera assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioera to Conglomerates industry mean.
  • A Debt to Asset Ratio of 2.77 means that Bioera assets are financed with 277.1% credit (debt) and the remaining percentage (100% - 277.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioera:

  • The MRQ is 2.771. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.729. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.771TTM1.729+1.042
TTM1.729YOY1.134+0.595
TTM1.7295Y1.254+0.475
5Y1.25410Y0.956+0.298
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7710.559+2.212
TTM1.7290.560+1.169
YOY1.1340.563+0.571
5Y1.2540.572+0.682
10Y0.9560.554+0.402
1.4.2. Debt to Equity Ratio

Measures if Bioera is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioera to the Conglomerates industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioera:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.534-5.534
TTM5.534YOY9.844-4.310
TTM5.5345Y11.045-5.511
5Y11.04510Y6.505+4.541
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.329-1.329
TTM5.5341.331+4.203
YOY9.8441.423+8.421
5Y11.0451.584+9.461
10Y6.5051.545+4.960

2. Market Valuation of Bioera

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Bioera generates.

  • Above 15 is considered overpriced but always compare Bioera to the Conglomerates industry mean.
  • A PE ratio of -0.73 means the investor is paying €-0.73 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioera:

  • The EOD is -0.114. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.729. Based on the earnings, the company is expensive. -2
  • The TTM is -1.455. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.114MRQ-0.729+0.615
MRQ-0.729TTM-1.455+0.726
TTM-1.455YOY0.388-1.843
TTM-1.4555Y-1.397-0.058
5Y-1.39710Y0.898-2.296
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1147.636-7.750
MRQ-0.7297.232-7.961
TTM-1.4558.001-9.456
YOY0.3887.324-6.936
5Y-1.3979.255-10.652
10Y0.89815.679-14.781
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioera:

  • The EOD is 0.079. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.505. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.380. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.079MRQ0.505-0.426
MRQ0.505TTM0.380+0.124
TTM0.380YOY-1.834+2.214
TTM0.3805Y-13.011+13.391
5Y-13.01110Y-7.062-5.949
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD0.0791.498-1.419
MRQ0.5051.805-1.300
TTM0.3801.618-1.238
YOY-1.8340.465-2.299
5Y-13.0110.577-13.588
10Y-7.0620.114-7.176
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bioera is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Conglomerates industry mean).
  • A PB ratio of -1.73 means the investor is paying €-1.73 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioera:

  • The EOD is -0.272. Based on the equity, the company is expensive. -2
  • The MRQ is -1.732. Based on the equity, the company is expensive. -2
  • The TTM is -1.893. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.272MRQ-1.732+1.460
MRQ-1.732TTM-1.893+0.161
TTM-1.893YOY0.662-2.556
TTM-1.8935Y-0.413-1.481
5Y-0.41310Y0.051-0.464
Compared to industry (Conglomerates)
PeriodCompanyIndustry (mean)+/- 
EOD-0.2720.968-1.240
MRQ-1.7320.977-2.709
TTM-1.8930.978-2.871
YOY0.6621.069-0.407
5Y-0.4131.182-1.595
10Y0.0511.454-1.403
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bioera compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.195-0.069-65%0.124-258%-0.025-87%-0.029-85%
Book Value Per Share---0.248-0.114-54%-0.118-52%-0.136-45%0.274-190%
Current Ratio--0.0670.181-63%0.328-79%0.432-84%0.336-80%
Debt To Asset Ratio--2.7711.729+60%1.134+144%1.254+121%0.956+190%
Debt To Equity Ratio---5.534-100%9.844-100%11.045-100%6.505-100%
Dividend Per Share----0%-0%-0%0.005-100%
Eps---0.147-0.057-61%0.136-209%-0.012-92%-0.014-91%
Free Cash Flow Per Share--0.2130.119+79%-0.021+110%0.009+2294%-0.007+103%
Free Cash Flow To Equity Per Share--0.0040.000+728%-0.003+176%-0.004+205%0.002+108%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.744+34%
Intrinsic Value_10Y_max--6.037--------
Intrinsic Value_10Y_min--5.028--------
Intrinsic Value_1Y_max--0.128--------
Intrinsic Value_1Y_min--0.126--------
Intrinsic Value_3Y_max--0.749--------
Intrinsic Value_3Y_min--0.708--------
Intrinsic Value_5Y_max--1.807--------
Intrinsic Value_5Y_min--1.646--------
Market Cap1386485.400-537%8835244.5004773267.253+85%4171490.951+112%5068105.546+74%5529092.430+60%
Net Profit Margin---17.022-6.276-63%-0.450-97%-1.148-93%-0.574-97%
Operating Margin----0.2700%-0.3700%-0.1600%-0.0900%
Operating Ratio---0.045-100%0.080-100%0.704-100%0.953-100%
Pb Ratio-0.272+84%-1.732-1.893+9%0.662-362%-0.413-76%0.051-3472%
Pe Ratio-0.114+84%-0.729-1.455+100%0.388-288%-1.397+92%0.898-181%
Price Per Share0.067-537%0.4300.204+111%0.158+171%0.233+85%0.262+64%
Price To Free Cash Flow Ratio0.079-537%0.5050.380+33%-1.834+463%-13.011+2678%-7.062+1499%
Price To Total Gains Ratio-0.346+84%-2.202-4.732+115%-0.409-81%-2.847+29%-2.563+16%
Quick Ratio--0.0160.184-92%0.278-94%0.324-95%0.454-97%
Return On Assets---1.052-0.412-61%0.369-385%-0.017-98%-0.013-99%
Return On Equity----0.1180%1.806-100%0.032-100%-0.0040%
Total Gains Per Share---0.195-0.069-65%0.124-258%-0.025-87%-0.024-88%
Usd Book Value---5499388.100-2859480.567-48%-2458607.050-55%-3032638.558-45%6076282.174-191%
Usd Book Value Change Per Share---0.210-0.074-65%0.133-258%-0.027-87%-0.031-85%
Usd Book Value Per Share---0.267-0.123-54%-0.127-52%-0.147-45%0.296-190%
Usd Dividend Per Share----0%-0%-0%0.005-100%
Usd Eps---0.159-0.062-61%0.146-209%-0.013-92%-0.015-91%
Usd Free Cash Flow--4717765.6003124693.167+51%-623411.325+113%243366.889+1839%-86386.218+102%
Usd Free Cash Flow Per Share--0.2290.128+79%-0.023+110%0.010+2294%-0.008+103%
Usd Free Cash Flow To Equity Per Share--0.0040.000+728%-0.003+176%-0.004+205%0.002+108%
Usd Market Cap1494769.910-537%9525277.0955146059.426+85%4497284.395+112%5463924.589+74%5960914.549+60%
Usd Price Per Share0.073-537%0.4630.220+111%0.171+171%0.251+85%0.283+64%
Usd Profit---3266643.000-1495684.067-54%6259044.313-152%308506.826-1159%-33780.467-99%
Usd Revenue--191901.800214182.533-10%5347376.000-96%5139302.700-96%9593417.563-98%
Usd Total Gains Per Share---0.210-0.074-65%0.133-258%-0.027-87%-0.026-88%
 EOD+3 -5MRQTTM+11 -20YOY+12 -205Y+12 -2010Y+14 -20

3.2. Fundamental Score

Let's check the fundamental score of Bioera based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.114
Price to Book Ratio (EOD)Between0-1-0.272
Net Profit Margin (MRQ)Greater than0-17.022
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.016
Current Ratio (MRQ)Greater than10.067
Debt to Asset Ratio (MRQ)Less than12.771
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.052
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Bioera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.311
Ma 20Greater thanMa 500.076
Ma 50Greater thanMa 1000.066
Ma 100Greater thanMa 2000.057
OpenGreater thanClose0.068
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets3,135
Total Liabilities8,367
Total Stockholder Equity-5,276
 As reported
Total Liabilities 8,367
Total Stockholder Equity+ -5,276
Total Assets = 3,135

Assets

Total Assets3,135
Total Current Assets1,646
Long-term Assets1,489
Total Current Assets
Cash And Cash Equivalents 434
Net Receivables 10
Other Current Assets 62
Total Current Assets  (as reported)1,646
Total Current Assets  (calculated)506
+/- 1,140
Long-term Assets
Property Plant Equipment 753
Long-term Assets  (as reported)1,489
Long-term Assets  (calculated)753
+/- 736

Liabilities & Shareholders' Equity

Total Current Liabilities7,487
Long-term Liabilities880
Total Stockholder Equity-5,276
Total Current Liabilities
Short Long Term Debt 2,957
Accounts payable 1,309
Other Current Liabilities 20
Total Current Liabilities  (as reported)7,487
Total Current Liabilities  (calculated)4,286
+/- 3,201
Long-term Liabilities
Long-term Liabilities  (as reported)880
Long-term Liabilities  (calculated)0
+/- 880
Total Stockholder Equity
Total Stockholder Equity (as reported)-5,276
Total Stockholder Equity (calculated)0
+/- 5,276
Other
Capital Stock5,386
Common Stock Shares Outstanding 12,098
Net Debt 2,523
Net Invested Capital -2,319
Net Working Capital -5,841
Property Plant and Equipment Gross 764



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-06-302022-12-312022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302009-12-312009-09-302009-06-302009-03-312008-12-312008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-31
> Total Assets 
39,572
37,000
43,914
87,412
87,599
84,021
84,021
112,962
112,962
111,452
111,452
111,915
111,915
111,475
111,475
116,447
114,243
114,243
0
91,508
46,989
38,387
38,387
40,811
42,093
45,476
45,476
45,942
45,942
46,818
46,818
45,440
45,440
41,721
41,834
42,154
42,154
41,847
41,847
44,227
44,227
41,377
41,377
41,319
41,319
41,037
41,037
37,726
37,726
34,173
34,173
32,656
32,656
29,723
29,723
26,845
26,845
0
21,571
0
18,188
0
16,687
0
15,683
0
16,370
0
4,710
2,881
3,135
3,1352,8814,710016,370015,683016,687018,188021,571026,84526,84529,72329,72332,65632,65634,17334,17337,72637,72641,03741,03741,31941,31941,37741,37744,22744,22741,84741,84742,15442,15441,83441,72145,44045,44046,81846,81845,94245,94245,47645,47642,09340,81138,38738,38746,98991,5080114,243114,243116,447111,475111,475111,915111,915111,452111,452112,962112,96284,02184,02187,59987,41243,91437,00039,572
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,697
20,697
16,649
16,649
16,670
16,670
15,533
15,533
14,194
14,194
12,569
12,569
8,691
8,691
6,345
6,345
5,285
5,285
3,069
3,069
3,357
3,357
1,502
1,502
529
1,646
1,6465291,5021,5023,3573,3573,0693,0695,2855,2856,3456,3458,6918,69112,56912,56914,19414,19415,53315,53316,67016,67016,64916,64920,69720,697000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,499
3,499
554
554
630
630
702
702
530
530
201
109
0
95
0
225
0
45
0
20
0
0
0
30
15
434
434153000020045022509501092015305307027026306305545543,4993,499000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
989
0
420
41
0
0414200989000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
9,742
0
14,406
23,793
23,980
26,858
26,858
34,632
39,141
39,067
39,067
34,455
34,451
38,408
38,408
36,677
45,473
45,473
0
40,313
21,430
10,171
10,466
10,793
10,271
10,386
10,386
13,946
13,946
12,163
12,207
11,612
11,612
11,811
11,980
12,822
12,822
11,991
11,991
11,742
11,742
11,484
11,484
11,481
11,481
11,417
11,417
10,729
10,729
11,278
11,278
10,355
10,355
9,743
9,743
9,176
7,567
6,753
6,753
4,797
4,797
3,918
3,918
2,589
2,589
2,186
2,186
1,463
1,463
0
10
1001,4631,4632,1862,1862,5892,5893,9183,9184,7974,7976,7536,7537,5679,1769,7439,74310,35510,35511,27811,27810,72910,72911,41711,41711,48111,48111,48411,48411,74211,74211,99111,99112,82212,82211,98011,81111,61211,61212,20712,16313,94613,94610,38610,38610,27110,79310,46610,17121,43040,313045,47345,47336,67738,40838,40834,45134,45539,06739,06739,14134,63226,85826,85823,98023,79314,40609,742
       Other Current Assets 
213
18,392
0
375
375
726
726
4,976
490
1,026
1,026
2,594
2,598
787
787
1,941
1,314
1,314
0
1,322
1,178
155
0
331
2,782
52
52
2,230
2,230
102
58
5,546
5,546
2,253
2,084
2,338
2,338
2,915
2,614
3,138
3,138
2,708
2,708
2,556
2,556
474
474
560
560
86
86
372
372
379
379
413
180
185
185
544
544
507
507
72
72
1,057
1,057
9
9
39
62
6239991,0571,057727250750754454418518518041337937937237286865605604744742,5562,5562,7082,7083,1383,1382,6142,9152,3382,3382,0842,2535,5465,546581022,2302,23052522,78233101551,1781,32201,3141,3141,9417877872,5982,5941,0261,0264904,976726726375375018,392213
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,276
0
12,880
0
11,843
0
11,402
0
12,614
0
0
0
3,208
2,352
1,489
1,4892,3523,20800012,614011,402011,843012,880014,27600000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
8,628
0
6,949
7,516
7,516
7,613
7,613
8,321
8,321
8,422
8,422
7,877
7,877
8,104
8,104
8,201
9,362
9,362
0
12,391
4,670
3,762
3,762
3,734
3,745
3,626
3,626
2,053
2,053
2,622
2,622
1,527
1,527
1,482
1,595
2,333
2,333
3,078
3,078
4,384
4,384
3,809
3,809
3,803
3,803
4,277
4,277
4,374
4,374
3,910
3,910
3,599
3,599
3,643
3,643
3,424
3,424
2,984
2,984
3,085
3,085
2,757
2,757
984
984
888
888
961
961
752
753
7537529619618888889849842,7572,7573,0853,0852,9842,9843,4243,4243,6433,6433,5993,5993,9103,9104,3744,3744,2774,2773,8033,8033,8093,8094,3844,3843,0783,0782,3332,3331,5951,4821,5271,5272,6222,6222,0532,0533,6263,6263,7453,7343,7623,7624,67012,39109,3629,3628,2018,1048,1047,8777,8778,4228,4228,3218,3217,6137,6137,5167,5166,94908,628
       Goodwill 
8,532
0
0
14,969
14,968
15,197
15,197
28,118
28,118
29,136
29,136
29,160
29,160
29,020
29,020
30,444
28,165
28,165
0
16,928
8,389
11,605
11,605
11,605
11,605
11,442
11,442
11,442
11,442
12,078
12,078
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
11,442
7,675
7,675
7,675
7,675
7,092
7,092
7,092
7,092
6,346
6,346
5,957
5,957
0
5,957
0
5,957
0
5,755
0
0
0
0
0
0
0
0
000000005,75505,95705,95705,9575,9576,3466,3467,0927,0927,0927,0927,6757,6757,6757,67511,44211,44211,44211,44211,44211,44211,44211,44211,44211,44211,44211,44211,44211,44212,07812,07811,44211,44211,44211,44211,60511,60511,60511,6058,38916,928028,16528,16530,44429,02029,02029,16029,16029,13629,13628,11828,11815,19715,19714,96814,969008,532
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,604
3,604
4,704
4,704
4,161
4,161
3,959
3,959
4,095
4,095
1,927
1,927
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,9271,9274,0954,0953,9593,9594,1614,1614,7044,7043,6043,604000000000000000000000000000000000000000000000
       Intangible Assets 
9,219
0
9,951
15,746
15,746
16,000
16,000
28,958
28,958
29,964
29,964
30,086
30,086
29,804
29,804
31,402
29,152
29,152
0
17,479
8,603
11,703
11,703
11,698
11,850
11,638
11,638
11,639
11,639
13,670
13,670
11,677
11,677
11,694
11,694
11,761
11,761
11,928
11,928
11,975
11,975
11,938
11,938
11,961
11,961
8,070
8,070
8,004
8,004
7,350
7,350
236
236
142
142
1,945
1,945
0
828
0
64
0
60
0
0
0
0
0
0
0
0
0000000060064082801,9451,9451421422362367,3507,3508,0048,0048,0708,07011,96111,96111,93811,93811,97511,97511,92811,92811,76111,76111,69411,69411,67711,67713,67013,67011,63911,63911,63811,63811,85011,69811,70311,7038,60317,479029,15229,15231,40229,80429,80430,08630,08629,96429,96428,95828,95816,00016,00015,74615,7469,95109,219
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,276
0
12,880
0
0
0
0
0
0
0
0
0
1
0
0
00100000000012,880014,27600000000000000000000000000000000000000000000000000000000
> Total Liabilities 
31,266
27,166
33,546
61,025
61,212
57,619
57,619
82,867
82,867
80,440
80,440
80,881
80,881
81,165
81,165
88,773
94,752
94,752
0
96,205
58,665
48,065
48,065
30,806
32,124
27,613
27,613
25,436
25,436
28,766
28,766
28,543
28,543
21,292
21,405
22,896
22,896
24,719
24,719
28,932
28,932
29,235
29,235
30,303
30,303
30,274
30,274
28,838
28,838
29,362
29,362
29,278
29,278
27,015
27,015
28,870
28,870
0
28,516
0
26,958
0
27,721
0
14,096
0
17,632
0
6,304
7,982
8,367
8,3677,9826,304017,632014,096027,721026,958028,516028,87028,87027,01527,01529,27829,27829,36229,36228,83828,83830,27430,27430,30330,30329,23529,23528,93228,93224,71924,71922,89622,89621,40521,29228,54328,54328,76628,76625,43625,43627,61327,61332,12430,80648,06548,06558,66596,205094,75294,75288,77381,16581,16580,88180,88180,44080,44082,86782,86757,61957,61961,21261,02533,54627,16631,266
   > Total Current Liabilities 
27,028
13,300
21,757
43,413
43,600
40,105
40,105
63,640
63,640
60,325
60,325
54,796
54,796
55,822
55,822
76,004
65,455
65,455
0
86,681
50,510
41,043
41,043
22,139
23,623
19,456
19,456
18,159
18,159
19,256
19,256
20,417
20,417
14,942
15,055
17,313
17,313
18,623
18,623
21,183
21,183
23,582
23,582
24,237
24,237
22,306
22,306
21,451
21,451
22,328
22,328
20,808
20,808
19,673
19,673
20,396
20,396
19,793
19,793
17,953
17,953
17,806
17,806
9,393
9,393
10,199
10,199
6,297
6,297
7,868
7,487
7,4877,8686,2976,29710,19910,1999,3939,39317,80617,80617,95317,95319,79319,79320,39620,39619,67319,67320,80820,80822,32822,32821,45121,45122,30622,30624,23724,23723,58223,58221,18321,18318,62318,62317,31317,31315,05514,94220,41720,41719,25619,25618,15918,15919,45619,45623,62322,13941,04341,04350,51086,681065,45565,45576,00455,82255,82254,79654,79660,32560,32563,64063,64040,10540,10543,60043,41321,75713,30027,028
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,132
13,132
12,216
12,216
8,251
8,251
6,505
6,505
5,472
5,472
4,492
4,603
0
0
0
0
0
0
0
0
0
4,268
0
35
0
0
003504,2680000000004,6034,4925,4725,4726,5056,5058,2518,25112,21612,21613,13213,132000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,132
13,132
12,216
12,216
8,251
8,251
6,505
6,505
5,472
5,472
4,492
4,603
0
4,911
0
4,433
0
5,797
0
4,497
0
0
0
2,849
2,995
2,957
2,9572,9952,8490004,49705,79704,43304,91104,6034,4925,4725,4726,5056,5058,2518,25112,21612,21613,13213,132000000000000000000000000000000000000000000000
       Accounts payable 
11,260
0
14,905
22,248
22,484
20,780
20,780
29,881
29,881
29,260
29,260
30,611
30,611
30,508
30,508
35,699
36,846
36,846
0
38,007
18,350
10,958
10,958
10,788
13,140
11,328
11,328
10,695
10,695
11,297
11,297
8,449
8,449
9,224
9,224
9,808
9,808
11,678
11,678
11,692
11,692
11,902
11,902
11,142
11,142
10,967
10,967
10,259
10,259
11,000
11,000
11,426
11,426
10,871
10,871
10,895
10,895
9,815
9,815
8,250
8,250
6,445
6,445
1,386
1,386
1,742
1,742
999
999
1,343
1,309
1,3091,3439999991,7421,7421,3861,3866,4456,4458,2508,2509,8159,81510,89510,89510,87110,87111,42611,42611,00011,00010,25910,25910,96710,96711,14211,14211,90211,90211,69211,69211,67811,6789,8089,8089,2249,2248,4498,44911,29711,29710,69510,69511,32811,32813,14010,78810,95810,95818,35038,007036,84636,84635,69930,50830,50830,61130,61129,26029,26029,88129,88120,78020,78022,48422,24814,905011,260
       Other Current Liabilities 
11,826
13,300
2,884
9,052
9,003
6,401
6,401
15,422
15,422
3,955
3,955
3,699
3,699
3,919
3,919
3,988
3,954
3,954
0
8,844
6,810
5,586
5,586
5,075
4,928
4,280
4,280
5,678
5,678
4,955
4,955
7,853
7,853
4,292
4,405
5,392
5,392
4,872
4,872
5,060
5,060
4,980
4,980
4,630
4,630
2,622
2,622
2,747
2,747
2,883
2,883
1,498
1,498
1,967
1,967
2,160
410
2,486
2,486
2,864
2,864
3,384
3,384
2,544
2,544
4,068
4,068
2,103
2,103
7
20
2072,1032,1034,0684,0682,5442,5443,3843,3842,8642,8642,4862,4864102,1601,9671,9671,4981,4982,8832,8832,7472,7472,6222,6224,6304,6304,9804,9805,0605,0604,8724,8725,3925,3924,4054,2927,8537,8534,9554,9555,6785,6784,2804,2804,9285,0755,5865,5866,8108,84403,9543,9543,9883,9193,9193,6993,6993,9553,95515,42215,4226,4016,4019,0039,0522,88413,30011,826
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,474
0
8,723
0
9,005
0
8,356
0
4,703
0
0
0
77
70
880
88070770004,70308,35609,00508,72308,47400000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,081
0
6,686
0
3,755
0
3,260
0
49
51
0
0514903,26003,75506,68607,081000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,132
-13,132
-12,216
-12,216
-8,251
-8,251
-6,505
-6,505
-5,472
-5,472
-4,492
-2,457
0
939
0
1,282
0
979
0
11
0
-4,268
0
-35
0
0
00-350-4,268011097901,28209390-2,457-4,492-5,472-5,472-6,505-6,505-8,251-8,251-12,216-12,216-13,132-13,132000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
0
96
0
15
0
172
0
95
0
0
0
1
1
0
01100095017201509605100000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
3,144
4,217
4,523
19,110
19,110
18,845
18,845
21,875
21,875
22,813
22,813
22,817
22,817
21,672
21,672
19,685
13,407
13,407
19,491
0
0
0
0
5,786
10,024
17,816
17,816
20,484
20,484
18,045
18,045
16,929
16,929
19,237
19,237
18,067
18,067
15,946
15,946
14,719
14,719
12,304
12,304
11,208
11,208
11,823
11,823
10,326
10,326
7,531
7,531
6,236
6,236
5,050
5,050
1,062
1,062
0
-8,407
0
-4,729
0
-11,583
0
-912
0
-1,262
0
-1,594
-5,101
-5,276
-5,276-5,101-1,5940-1,2620-9120-11,5830-4,7290-8,40701,0621,0625,0505,0506,2366,2367,5317,53110,32610,32611,82311,82311,20811,20812,30412,30414,71914,71915,94615,94618,06718,06719,23719,23716,92916,92918,04518,04520,48420,48417,81617,81610,0245,786000019,49113,40713,40719,68521,67221,67222,81722,81722,81322,81321,87521,87518,84518,84519,11019,1104,5234,2173,144
   Common Stock
1,375
4,217
1,375
1,745
1,745
1,740
1,740
1,761
1,761
1,783
1,783
1,776
1,776
1,764
1,764
1,761
1,788
1,788
0
1,788
1,788
1,788
1,788
9,000
9,000
18,000
18,000
15,716
15,716
15,716
15,716
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,000
13,970
13,970
14,330
14,330
14,990
14,990
15,180
15,180
4,180
4,180
4,245
4,245
4,302
4,302
4,403
4,403
4,484
4,484
4,484
4,484
4,491
0
04,4914,4844,4844,4844,4844,4034,4034,3024,3024,2454,2454,1804,18015,18015,18014,99014,99014,33014,33013,97013,97013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00013,00015,71615,71615,71615,71618,00018,0009,0009,0001,7881,7881,7881,78801,7881,7881,7611,7641,7641,7761,7761,7831,7831,7611,7611,7401,7401,7451,7451,3754,2171,375
   Retained Earnings 
72
0
1,006
3,182
3,182
2,435
2,435
7,011
5,308
6,439
6,439
6,793
6,793
6,232
6,232
4,356
0
0
0
0
0
0
0
0
1,024
1,676
1,676
4,768
4,768
2,329
2,329
3,929
3,929
6,237
6,237
5,067
5,067
2,946
2,946
1,719
1,719
0
0
0
0
-1,177
-1,177
-2,674
-2,674
-6,969
-6,969
-8,264
-8,264
-10,450
-10,450
-14,438
-15,213
-12,587
-12,587
-8,974
-8,974
-17,253
-17,253
-9,060
-9,060
-10,345
-10,345
-2,454
-2,454
-9,592
-16,093
-16,093-9,592-2,454-2,454-10,345-10,345-9,060-9,060-17,253-17,253-8,974-8,974-12,587-12,587-15,213-14,438-10,450-10,450-8,264-8,264-6,969-6,969-2,674-2,674-1,177-1,17700001,7191,7192,9462,9465,0675,0676,2376,2373,9293,9292,3292,3294,7684,7681,6761,6761,024000000004,3566,2326,2326,7936,7936,4396,4395,3087,0112,4352,4353,1823,1821,006072
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000-1,240-1,131-1,131-560-560-216-2160-1,7040000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
530
530
170
170
510
510
320
320
0
0
0
0
1,761
1,761
3,745
3,745
4,599
4,599
-3,623
-3,623
0
0
00-3,623-3,6234,5994,5993,7453,7451,7611,76100003203205105101701705305300000000000000000000000000000000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue560
Cost of Revenue-56
Gross Profit504504
 
Operating Income (+$)
Gross Profit504
Operating Expense-3,339
Operating Income-3,605-2,835
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,284
Selling And Marketing Expenses0
Operating Expense3,3391,284
 
Net Interest Income (+$)
Interest Income284
Interest Expense-135
Other Finance Cost-415
Net Interest Income-266
 
Pretax Income (+$)
Operating Income-3,605
Net Interest Income-266
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,091-3,605
EBIT - interestExpense = -135
-3,988
-3,853
Interest Expense135
Earnings Before Interest and Taxes (EBIT)0-3,956
Earnings Before Interest and Taxes (EBITDA)-3,923
 
After tax Income (+$)
Income Before Tax-4,091
Tax Provision-22
Net Income From Continuing Ops-4,113-4,113
Net Income-3,988
Net Income Applicable To Common Shares-3,987
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0266
 

Technical Analysis of Bioera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioera. The general trend of Bioera is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioera.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.108 < 0.126 < 0.139.

The bearish price targets are: 0.0496 > 0.049 > 0.048.

Tweet this
Bioera Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioera. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioera Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioera. The current macd is 0.00146932.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioera price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bioera. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bioera price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bioera Daily Moving Average Convergence/Divergence (MACD) ChartBioera Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioera. The current adx is 16.34.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bioera shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bioera Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioera. The current sar is 0.11891722.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bioera Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioera. The current rsi is 46.31. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Bioera Daily Relative Strength Index (RSI) ChartBioera Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioera. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bioera price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bioera Daily Stochastic Oscillator ChartBioera Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioera. The current cci is -49.21977815.

Bioera Daily Commodity Channel Index (CCI) ChartBioera Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioera. The current cmo is -17.00254005.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bioera Daily Chande Momentum Oscillator (CMO) ChartBioera Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioera. The current willr is -93.01587302.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bioera Daily Williams %R ChartBioera Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bioera.

Bioera Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioera. The current atr is 0.0105244.

Bioera Daily Average True Range (ATR) ChartBioera Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioera. The current obv is 1,865,770.

Bioera Daily On-Balance Volume (OBV) ChartBioera Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioera. The current mfi is 44.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bioera Daily Money Flow Index (MFI) ChartBioera Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioera.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Bioera Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.311
Ma 20Greater thanMa 500.076
Ma 50Greater thanMa 1000.066
Ma 100Greater thanMa 2000.057
OpenGreater thanClose0.068
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bioera with someone you think should read this too:
  • Are you bullish or bearish on Bioera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioera

I send you an email if I find something interesting about Bioera.


Comments

How you think about this?

Leave a comment

Stay informed about Bioera.

Receive notifications about Bioera in your mailbox!